JRCT ID: jRCT1050230133
Registered date:21/11/2023
Measurement of biomarkers using existing samples from Phase 1 study of EA3571 in healthy adult subjects
Basic Information
| Recruitment status | Complete |
|---|---|
| Health condition(s) or Problem(s) studied | nonalcoholic steatohepatitis |
| Date of first enrollment | 03/12/2023 |
| Target sample size | 21 |
| Countries of recruitment | |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Plasma hormone concentration |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | < 45age old |
| Gender | Male |
| Include criteria | Subjects who received multiple doses of placebo-or EA3571 in a Phase 1 study of EA3571 in healthy adult subjects |
| Exclude criteria | Subjects who refused to participate in this study |
Related Information
| Primary Sponsor | Takeuchi Yutaka |
|---|---|
| Secondary Sponsor | EA Pharma Co., Ltd |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Yutaka Takeuchi |
| Address | 2-1-1, Irifune, Chuo-ku, Tokyo Tokyo Japan 104-0042 |
| Telephone | +81-3-6280-9600 |
| contact_ea@eapharma.co.jp | |
| Affiliation | EA Pharma Co., Ltd |
| Scientific contact | |
| Name | Yutaka Takeuchi |
| Address | 2-1-1, Irifune, Chuo-ku, Tokyo Tokyo Japan 104-0042 |
| Telephone | +81-3-6280-9600 |
| contact_ea@eapharma.co.jp | |
| Affiliation | EA Pharma Co., Ltd |